The British Menopause Society provides guidelines for assessing and managing unscheduled bleeding on Hormone Replacement Therapy (HRT). Recommendations include assessing cancer risk factors, adjusting HRT regimens, and offering examinations and investigations as needed. The document emphasizes the importance of inclusive and appropriate care for individuals whose gender identity does not align with their assigned sex. Detailed assessments and initial investigations are recommended for women presenting with unscheduled bleeding on HRT. Endometrial cancer risk factors in women taking HRT are outlined, with recommendations for managing these risks based on different HRT regimens. Conservative management strategies and further assessment options are provided for women experiencing unscheduled bleeding on HRT.